Page 11 - 2018_10-Haematologica-web

haematologica Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
e455 NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents
Pedro Henrique Prata et al. http://www.haematologica.org/content/103/10/e455
e458 Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
Esteban Enrique Elías et al.
http://www.haematologica.org/content/103/10/e458
e462 Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era Anthony Mato et al.
http://www.haematologica.org/content/103/10/e462
e466 Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia Jorge J. Castillo et al.
http://www.haematologica.org/content/103/10/e466
e469 Phase I study of the heparanase inhibitor roneparstat: an innovative approach for multiple myeloma therapy Monica Galli et al.
http://www.haematologica.org/content/103/10/e469
e473 Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
Johannes M. Waldschmidt et al.
http://www.haematologica.org/content/103/10/e473
e480 Interleukin-22 levels are increased in gastrointestinal graft-versus-host disease in children Dana T. Lounder, et al.
http://www.haematologica.org/content/103/10/e480
Case Reports
Case Reports are available online only at www.haematologica.org/content/103/10.toc
e483 Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease Satheesh Chonat et al.
http://www.haematologica.org/content/103/10/e483
e486 Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia. Ulrike Bacher et al.
http://www.haematologica.org/content/103/10/e486
e489 Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia Chezi Ganzel et al.
http://www.haematologica.org/content/103/10/e489
Comments
Comments are available online only at www.haematologica.org/content/103/10.toc
e491 Infection prevention in patients with hereditary hemorrhagic telangiectasia Juan Rodríguez-García et al.
http://www.haematologica.org/content/103/10/e491
e492 Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations Hanny Al-Samkari et al.
http://www.haematologica.org/content/103/10/e493
Haematologica 2018; vol. 103 no. 10 - October 2018 http://www.haematologica.org/